NexHealth, which operates an EHR-integrated real-time scheduling platform for doctors, raises a $125M Series C led by Buckley Ventures at a $1B valuation
Katie Jennings / Forbes :
Context & Ripple Effects
NexHealth's arc has been fast: its $15M Series A in mid-2020 funded an automated appointment system for small medical and dental practices, and the new $125M Series C — led by Buckley Ventures at a $1B valuation — arrives less than two years later with the platform repositioned around real-time scheduling integrated directly into EHRs.
The round also fits a funding pattern in adjacent healthcare software: Rightway crossed the unicorn line at a $1.1B valuation weeks earlier, while EHR-adjacent players like Elation Health and data-interoperability startup Abacus Insights have been raising through the same window.
First-order effects
- NexHealth gains roughly eight times its Series A war chest to push EHR-integrated scheduling into more medical and dental practices, where booking currently runs on manual front-desk workflows.
- Buckley Ventures takes a lead position in a newly minted unicorn, betting that the scheduling layer — not the EHR itself — is where practice-side software value accrues.
Second-order effects
- EHR vendors whose suites include native scheduling now compete against a well-funded third party embedding itself inside their systems, forcing a build-versus-partner decision on the integration layer.
- Rival healthcare workflow startups such as Elation Health and H1 face a raised valuation benchmark set by Rightway's $1.1B round and NexHealth's $1B mark, pressuring their next fundraises to justify comparable multiples.
Third-order effects
- If the pattern holds, healthcare administrative software stratifies into EHRs as systems of record with venture-backed middleware companies competing to own the patient-facing workflow on top of them.
- Sustained unicorn-level funding for EHR-integrated tools points toward consolidation pressure on small-practice software, where independent vendors of scheduling and intake tools risk being squeezed between platform players and the EHR incumbents they depend on.
The trend: Venture capital is crowding into the middleware layer between electronic health records and patient-facing workflows, turning EHR-integrated startups into unicorns within two years of their Series A.